3-{4-Cyano-3-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxy]-phenyl}-propionic acid is a chiral compound featuring a cyanophenylpropionic acid core linked via a (R)-2-hydroxy-3-aminopropoxy chain to a 2-indan-2-yl-1,1-dimethylethyl group. This specific stereochemistry and structural arrangement are critical for its biological activity. This compound is a key intermediate in the synthesis of Propranolol-related beta-adrenergic receptor antagonists. More importantly, it serves as a crucial chiral building block for the development of novel, selective beta-3 adrenergic receptor (β3-AR) agonists. β3-AR agonists are a class of investigational drugs primarily targeted for the treatment of overactive bladder (OAB) and other urological disorders, as well as metabolic conditions. The (R)-enantiomer of this structure is essential for achieving the desired receptor binding affinity and selectivity. Its synthesis and application are central to medicinal chemistry research focused on cardiometabolic and urological therapeutics. Handling requires standard precautions for laboratory chemicals.